MEI Pharma (NASDAQ:MEIP) has launched a $100 million Litecoin (CRYPTO: LTC) treasury program, backed by Titan Partners Group ...

MEI Pharma, a publicly traded pharmaceutical company, closed a $100 million private placement to turn itself into a litecoin ...

MEI Pharma announces a $100 million private placement to adopt Litecoin as its primary treasury reserve asset.

MEI Pharma raises $100 million to buy Litecoin, boosting stock value and signaling confidence in LTC's future growth.

MEI Pharma unveils bold $100M Litecoin treasury plan with Titan, GSR, Litecoin Foundation, expanding altcoin adoption beyond ...

MEI Pharma commits $100M to Litecoin with Charlie Lee joining its board, signaling major institutional interest in LTC.

GSR announced an investment and strategic partnership with MEI Pharma in which it will serve as both strategic advisor and ...

Attention remains on large-cap tokens on Friday as crypto bills’ approval fueled crypto rallies. While Ethereum steadied ...

MEI Pharma, Inc. (MEIP) announced on Friday a $100 million private placement to initiate a Litecoin treasury strategy, sending the company's shares trading 37% higher at the time of writing. The ...

Litecoin price steadies at $110 as traders watch for a $150 breakout and rising demand from altcoin treasury buyers.

Shares of MEI Pharma hit a 52-week high after the company said a $100 million private placement will be used to adopt the cryptocurrency Litecoin as its treasury reserved asset. The stock was up 52% ...